Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Geier

Showing results (1-10 of 249) with videos related to

Pageof 25
Sort By:
Journal of Hepatology|January 18, 2011
Shedding new light on vitamin D and fatty liver diseaseAndreas Geier
Hepatology (Baltimore, Md.)|May 16, 2014
Hepatitis B virus: the "metabolovirus" highjacks cholesterol and bile acid metabolismAndreas Geier
MMW Fortschritte Der Medizin|January 31, 2014
[Hepatitis C update: what has changed? What can we expect in the near future?]Andreas Geier
MMW Fortschritte Der Medizin|March 9, 2016
[Hepatitis C]Johannes Weiß, Andreas Geier
Expert Review of Clinical Pharmacology|February 4, 2021
An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapyMonika Rau, Andreas Geier
Hepatology (Baltimore, Md.)|December 26, 2006
Bile acids are "homeotrophic" sensors of the functional hepatic capacity and regulate adaptive growth during liver regenerationAndreas Geier, Christian Trautwein
Expert Review of Clinical Pharmacology|March 10, 2017
Emerging therapies for NASH - the future is nowAndreas Geier, Monika Rau
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2011
Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitisBruno Stieger, Andreas Geier
Chirurgie (Heidelberg, Germany)|November 7, 2022
[72/f-Acute abdomen : Preparation for the medical specialist examination: part 24]Andreas Geier, Matthias Anthuber
Gut|March 30, 2020
Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?Andreas Geier, Jerome Boursier
Pageof 25

Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|January 18, 2011
Shedding new light on vitamin D and fatty liver diseaseAndreas Geier
Hepatology (Baltimore, Md.)|May 16, 2014
Hepatitis B virus: the "metabolovirus" highjacks cholesterol and bile acid metabolismAndreas Geier
MMW Fortschritte Der Medizin|January 31, 2014
[Hepatitis C update: what has changed? What can we expect in the near future?]Andreas Geier
MMW Fortschritte Der Medizin|March 9, 2016
[Hepatitis C]Johannes Weiß, Andreas Geier
Expert Review of Clinical Pharmacology|February 4, 2021
An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapyMonika Rau, Andreas Geier
Hepatology (Baltimore, Md.)|December 26, 2006
Bile acids are "homeotrophic" sensors of the functional hepatic capacity and regulate adaptive growth during liver regenerationAndreas Geier, Christian Trautwein
Expert Review of Clinical Pharmacology|March 10, 2017
Emerging therapies for NASH - the future is nowAndreas Geier, Monika Rau
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2011
Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitisBruno Stieger, Andreas Geier
Chirurgie (Heidelberg, Germany)|November 7, 2022
[72/f-Acute abdomen : Preparation for the medical specialist examination: part 24]Andreas Geier, Matthias Anthuber
Gut|March 30, 2020
Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?Andreas Geier, Jerome Boursier
Pageof 25